In the context of amyotrophic lateral sclerosis (ALS), another neurodegenerative disorder, two recent cross-sectional casecontrol studies examined the role of metabolic biomarkers, including GLP-1, in the progression and pathogenesis of ALS [65, 66]
E1 is a TPP-dependent -ketoacid dehydrogenase, E2 is a dihydrolipoamide transacetylase that binds one or two lipoyl groups via covalent amide linkages to lysine residues, and E3 is an FAD-containing dihydrolipoamide dehydrogenase that re-oxidizes dihydrolipoamide using NAD +
A word on the drug itself: any decision about a GLP-1 medication, including dose, timing, or stopping, is a conversation for you and your doctor
Dexamethasone suppression test is ordered to rule out Cushings syndrome, a condition of excess cortisol that can cause weight gain This test helps determine whether weight gain is due to a hormonal disorder rather than primary obesity Identifying underlying endocrine causes is important before starting weight-loss medications 9
Desperate people will still flock to them in the face of chronic pain or terminal illness, encouraged by emotional testimonials, and some of them will feel an improvement
To improve the safety of medication use, as with prescribing, deprescribing should be a patient-centered approach